Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
48,700
+3,600 (7.98%)
At close: Jul 18, 2025, 3:30 PM KST

Next Biomedical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
395,782331,554----
Upgrade
Enterprise Value
365,126316,300----
Upgrade
Last Close Price
48700.0041000.00----
Upgrade
PE Ratio
141.66115.95----
Upgrade
PS Ratio
36.1634.74----
Upgrade
PB Ratio
8.747.34----
Upgrade
P/TBV Ratio
8.807.39----
Upgrade
EV/Sales Ratio
33.3633.15----
Upgrade
Debt / Equity Ratio
0.240.240.700.566.25-0.37
Upgrade
Asset Turnover
0.250.220.160.080.070.09
Upgrade
Inventory Turnover
1.621.601.371.611.831.23
Upgrade
Quick Ratio
3.603.681.351.381.700.18
Upgrade
Current Ratio
3.853.951.571.591.820.24
Upgrade
Return on Equity (ROE)
9.02%9.28%-41.64%-46.30%--
Upgrade
Return on Assets (ROA)
-5.17%-5.05%-10.57%-10.03%-13.55%-12.52%
Upgrade
Return on Capital (ROIC)
-5.46%-5.31%-11.14%-10.68%-64.38%-4371.23%
Upgrade
Earnings Yield
0.71%0.86%----
Upgrade
FCF Yield
-0.24%-0.50%----
Upgrade
Buyback Yield / Dilution
-24.75%-17.78%-1.10%-28.34%-13.05%-199.99%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.